RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: We also published a set of Best Practices for structuring these data at NCBI (raw data to SRA + metadata to Biosample), rec…
We also published a set of Best Practices for structuring these data at NCBI (raw data to SRA + metadata to Biosample), recommending this primary data model as a consistent data object for submitters and downstream app developers: https://t.co/QGuo77XTCz
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
A new blog post by @SrimathySriskan about #OneHealth interdisciplinary collaboration and some ways that journals can promote it. One example is this review by Ruth Timme et al. on best practices to ensure interoperability of genomic data from bacteria: h
@TCIAMN Here’s an example: https://t.co/sFoHMZ2yQu
RT @VirologyJ: The holistic approach of #OneHealth, which sees human, animal, plant, and environmental health as a unit, rather than discre…
RT @VirologyJ: The holistic approach of #OneHealth, which sees human, animal, plant, and environmental health as a unit, rather than discre…
The holistic approach of #OneHealth, which sees human, animal, plant, and environmental health as a unit, rather than discrete parts, requires standardized methods for communicating and archiving data. Read more @OneHealthPF #OneHealthDay https://t.co/nlND
RT @DoctorRuth: Great talk from @ErrolStrain covering QC threshold recommendations for GenomeTrakr data, also outlined in our recent paper:…
RT @DoctorRuth: Great talk from @ErrolStrain covering QC threshold recommendations for GenomeTrakr data, also outlined in our recent paper:…
RT @DoctorRuth: Great talk from @ErrolStrain covering QC threshold recommendations for GenomeTrakr data, also outlined in our recent paper:…
RT @DoctorRuth: Great talk from @ErrolStrain covering QC threshold recommendations for GenomeTrakr data, also outlined in our recent paper:…
Great talk from @ErrolStrain covering QC threshold recommendations for GenomeTrakr data, also outlined in our recent paper: https://t.co/x05HRQvoAj #GenomeTrakr2020 https://t.co/oXCUmMu4hD
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
@cmyeaton @NatSecBio @majohanss Food safety genomics researchers have been working on open data standards as well— tracking, tracing, and stopping outbreaks require effective information sharing! https://t.co/sFoHMZ2yQu
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @VirologyJ: Optimizing open data to support one health: best practices to ensure interoperability of genomic data from bacterial pathoge…
Optimizing open data to support one health: best practices to ensure interoperability of genomic data from bacterial pathogens https://t.co/nlNDb8QBXh https://t.co/6zMxoEroYE
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
Roadmap for open genomics epidemiology and with link to protocols… Congrats @DoctorRuth and all FDA group!
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
Ping @SidThakur_AMR
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
RT @DoctorRuth: In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for p…
In 2012 it was a SERIOUS uphill climb convincing folks (incl. those w/in FDA) that an open genomic epidemiology model for pathogen surveillance was a good idea. 7 years later, it's the norm. Here's our roadmap for how to do it: https://t.co/x05HRQvoAj #Ge